Express Scripts Holding Co (ESRX)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Express Scripts Holding Co (ESRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012277
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Express Scripts Holding Company (Express Scripts) is a pharmacy benefit management (PBM) company. It provides integrated pharmacy-benefit management services such as home delivery pharmacy services, specialty benefit management, network-pharmacy claims processing, formulary management, and medical and drug data analysis services. It also distributes a wide range of biopharmaceutical products and prescription drugs for specialty and orphan diseases; and provides cost-management and patient-care services. Express Scripts caters its services to clinics, managed care organizations, providers, hospitals, employers, union-sponsored benefit plans, health insurers, third-party administrators, workers’ compensation plans and government health programs. Express Scripts is headquartered in St. Louis, Missouri, the US.

Express Scripts Holding Co (ESRX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Express Scripts Holding Co, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Express Scripts Holding Co, Medical Devices Deals, 2011 to YTD 2017 10
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Avista Capital Partners to Acquire United BioSource from Express Scripts 12
Parthenon Capital Acquires Bracket Global From Express Scripts 13
Symphony Technology Acquires Market Access And Data Analytics Divisions Of United BioSource 14
Halifax Group Completes Management Buyout Of Envision Pharma 15
Express Scripts Receives Offer From TRC Capital To Acquire 0.24% Stake For Up To US$112 Million 16
ABS Capital Acquires ConnectYourCare From Express Scripts 17
Partnerships 18
Pfizer Enters Into Research Agreement With Medco Health Solutions And United BioSource 18
Debt Offering 20
Express Scripts Completes Private Placement Of Senior Notes Due 2017 For US$1.5 Billion 20
Express Scripts Completes Private Placement Of Senior Notes Due 2022 For US$1 Billion 21
Express Scripts Completes Private Placement Of Senior Notes Due 2015 For US$1 Billion 22
Express Scripts Completes Private Placement Of Senior Notes Due 2041 For US$700 Million 23
Express Scripts Completes Private Placement Of Senior Notes Due 2021 For US$1.25 Billion 24
Express Scripts Completes Private Placement Of Senior Notes Due 2014 For US$900 Million 25
Express Scripts Completes Private Placement Of Senior Notes Due 2016 For US$1.25 Billion 26
Express Scripts Completes Public Offering Of Senior Notes Due 2016 For US$1,500 Million 27
Acquisition 29
Express Scripts Completes Acquisition Of Medco Health For US$29 Billion 29
Express Scripts Holding Co – Key Competitors 31
Express Scripts Holding Co – Key Employees 32
Express Scripts Holding Co – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 36
Financial Announcements 36
Oct 24, 2017: Express Scripts Announces 2017 Third Quarter Results 36
Jul 25, 2017: Express Scripts Announces 2017 Second Quarter Results 37
Apr 24, 2017: Express Scripts Announces 2017 First Quarter Results 38
Feb 14, 2017: Express Scripts Announces 2016 Fourth Quarter and Full Year Results 39
Oct 25, 2016: Express Scripts Announces 2016 Third Quarter Results 40
Jul 25, 2016: Express Scripts Announces 2016 Second Quarter Results; Narrows 2016 Full-Year Adjusted Diluted EPS Guidance Range; Raises Mid-Point; Provides 2016 Third Quarter Guidance 41
Apr 25, 2016: Express Scripts Announces 2016 First Quarter Results; Increases 2016 Guidance Range: Raises Mid-Point; Provides 2016 Second Quarter Guidance 42
Feb 16, 2016: Express Scripts Announces 2015 4th Quarter and Full Year Results; Narrows 2016 Guidance Range: Raises Mid-Point 44
Corporate Communications 45
Oct 24, 2017: Express Scripts Appoints James M. Havel Chief Financial Officer 45
Jun 27, 2017: Express Scripts Elects Kathleen M. Mazzarella to Board of Directors 46
Legal and Regulatory 47
Mar 21, 2016: Anthem Files Suit against Pharmacy Benefit Manager to Recover Damages for Pricing and Operations Issues 47
Government and Public Interest 48
Aug 25, 2017: Express Scripts Research Shows Significant Benefit of Adherence to Diabetes Medications 48
Product News 50
Dec 12, 2016: Express Scripts Announces Enhancements to Industry Leading SafeGuardRx Programs 50
Other Significant Developments 52
Oct 02, 2017: Express Scripts Introduces New Medicare Part D Saver Plan for 2018 52
Jun 07, 2017: Express Scripts Introduces Comprehensive Solution to Reduce Opioid Abuse 53
Jun 01, 2017: Express Scripts Expands SafeGuardRx Program to Improve Care for Pulmonary Conditions and Multiple Sclerosis 54
Dec 13, 2016: Lilly Announces Program To Provide Insulin At Discounted Prices 56
Sep 08, 2016: Express Scripts Launches Inflammatory Conditions Care Value Program, Making America’s Costliest Medication Class More Affordable 57
Aug 31, 2016: Express Scripts Launches Diabetes Care Value Program, Guaranteeing More Affordable, Higher-Quality Diabetes Care 59
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Express Scripts Holding Co, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Express Scripts Holding Co, Deals By Therapy Area, 2011 to YTD 2017 9
Express Scripts Holding Co, Medical Devices Deals, 2011 to YTD 2017 10
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Avista Capital Partners to Acquire United BioSource from Express Scripts 12
Parthenon Capital Acquires Bracket Global From Express Scripts 13
Symphony Technology Acquires Market Access And Data Analytics Divisions Of United BioSource 14
Halifax Group Completes Management Buyout Of Envision Pharma 15
Express Scripts Receives Offer From TRC Capital To Acquire 0.24% Stake For Up To US$112 Million 16
ABS Capital Acquires ConnectYourCare From Express Scripts 17
Pfizer Enters Into Research Agreement With Medco Health Solutions And United BioSource 18
Express Scripts Completes Private Placement Of Senior Notes Due 2017 For US$1.5 Billion 20
Express Scripts Completes Private Placement Of Senior Notes Due 2022 For US$1 Billion 21
Express Scripts Completes Private Placement Of Senior Notes Due 2015 For US$1 Billion 22
Express Scripts Completes Private Placement Of Senior Notes Due 2041 For US$700 Million 23
Express Scripts Completes Private Placement Of Senior Notes Due 2021 For US$1.25 Billion 24
Express Scripts Completes Private Placement Of Senior Notes Due 2014 For US$900 Million 25
Express Scripts Completes Private Placement Of Senior Notes Due 2016 For US$1.25 Billion 26
Express Scripts Completes Public Offering Of Senior Notes Due 2016 For US$1,500 Million 27
Express Scripts Completes Acquisition Of Medco Health For US$29 Billion 29
Express Scripts Holding Co, Key Competitors 31
Express Scripts Holding Co, Key Employees 32
Express Scripts Holding Co, Subsidiaries 34

★海外企業調査レポート[Express Scripts Holding Co (ESRX)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Foster Farms:企業の戦略・SWOT・財務情報
    Foster Farms - Strategy, SWOT and Corporate Finance Report Summary Foster Farms - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • PDC Energy Inc (PDCE):石油・ガス:M&Aディール及び事業提携情報
    Summary PDC Energy Inc (PDC Energy) is an oil and gas company that offers production, development, exploration and marketing of crude oil, natural gas and natural gas liquids. The company provides horizontal drilling and low-risk organic development of oil and natural gas reserves from shales and ti …
  • Timberwest Forest Corporation:企業の戦略・SWOT・財務分析
    Timberwest Forest Corporation - Strategy, SWOT and Corporate Finance Report Summary Timberwest Forest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Mitsubishi Materials Corp:企業の戦略・SWOT・財務情報
    Mitsubishi Materials Corp - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Materials Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • UGE International Ltd (UGE):企業の財務・戦略的SWOT分析
    Summary UGE International Ltd (UGE), formerly Way Ventures Inc, is a renewable energy company that operates through wind, solar, solar-wind technologies. The company offers products such as electronics and accessories, wind turbines, solar panels, energy storage systems, mounting system, electronics …
  • Centrexion Therapeutics Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Centrexion Therapeutics Corp (Centrexion Therapeutics), formerly Centrexion Corp is a developer of clinical pipelines of novel and non opioid chronic pain therapy products. The company offers products such as CNTX-4975, CNTX- 0290, CNTX-6970, CNTX-2022, CNTX-6016 and Intrathecalplatform. Its …
  • Terumo Corp (4543):医療機器:M&Aディール及び事業提携情報
    Summary Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial …
  • 1414 Degrees Ltd (14D):企業の財務・戦略的SWOT分析
    1414 Degrees Ltd (14D) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • FluoroPharma Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary FluoroPharma Medical Inc (FluoroPharma) is a molecular imaging company that develops and commercialize proprietary medical diagnostic imaging products. The company develops breakthrough positron emission tomography imaging agents for the assessment and detection of acute and chronic forms of …
  • Twist Bioscience Corp:医療機器:M&Aディール及び事業提携情報
    Summary Twist Bioscience Corp (Twist Bioscience) is a DNA specializing and development company that develops DNA products ad DNA synthesis process. The company provides products includes DNA pools for gRNA cloning such as unamplified oligo pools, cloning-ready oligo pools; protein scanning single va …
  • Investment Technology Group, Inc.:企業の戦略・SWOT・財務分析
    Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Seacor Holdings Inc (CKH):企業の財務・戦略的SWOT分析
    Summary Seacor Holdings Inc (Seacor) is a diversified holding company that offers domestic and international transportation, logistics and risk management consultancy services. The company offers ocean transportation and logistics services; inland transportation and logistics services; Witt O'Brien' …
  • Arcam AB:企業の戦略的SWOT分析
    Arcam AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Luna Innovations Inc (LUNA):医療機器:M&Aディール及び事業提携情報
    Summary Luna Innovations Inc (Luna) is an optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company provides products such as fiber optic sensing products, fiber optic test and measurement products, high speed optical pr …
  • Telecom Plus plc (TEP):企業の財務・戦略的SWOT分析
    Telecom Plus plc (TEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Checkmate Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Checkmate Pharmaceuticals Inc (Checkmate Pharmaceuticals) is a clinical stage company that discovers and develops immunotherapies to provide new treatment options for patients and the healthcare providers. The company’s lead product candidate, CMP-001, is a CpG oligonucleotides (CpG-A ODN) t …
  • Neonc Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NeOnc Technologies Inc (NTI) is an early-stage cancer biotechnology company that focuses on the development of intranasal inhalation and other non-invasive therapies for the treatment of malignant brain cancer, lung cancer and other brain cancers. The company’s product portfolio includes NEO …
  • Thomas & Betts Corp:企業の戦略的SWOT分析
    Thomas & Betts Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Thai Beverage Public Company Limited:戦略・SWOT・企業財務分析
    Thai Beverage Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thai Beverage Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Taneja Aerospace & Aviation Ltd.
    Taneja Aerospace & Aviation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taneja Aerospace & Aviation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆